No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DXC240517C23000
- 0.14
- +0.03+27.27%
15min DelayTrading May 14 09:45 ET
0.15High0.14Low
0.15Open0.11Pre Close2 Volume37 Open Interest23.00Strike Price29.00Turnover112.43%IV16.90%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.14Time Value100Contract SizeAmericanOptions Type0.1006Delta0.0803Gamma197.60Leverage Ratio-0.0509Theta0.0002Rho19.87Eff Leverage0.0034Vega
Intraday
- 5D
- 1D
News
Express News | NYSE Order Imbalance 82905.0 Shares on Buy Side
DXC Technology (DXC) to Report Q4 Earnings: What's in Store?
DXC Technology DXC is slated to report fourth-quarter fiscal 2024 results on May 16.
Shareholders in DXC Technology (NYSE:DXC) Are in the Red If They Invested Five Years Ago
Statistically speaking, long term investing is a profitable endeavour. But unfortunately, some companies simply don't succeed. For example the DXC Technology Company (NYSE:DXC) share price dropped 6
Express News | NYSE Order Imbalance 72385.0 Shares on Sell Side
Express News | NYSE Order Imbalance 65391.0 Shares on Buy Side
Express News | NYSE Order Imbalance 55273.0 Shares on Buy Side
Comments
Recent insider selling at DXC Technology, along with no insider buying in the past year, raises caution. Despite a reasonable degree of alignment due to insider ownership, the absence of insider buying and recent selling prompts caution about the company.
Have DXC Technology Insiders Been Selling Stock? 1
DXC Technology's CEO, Raul Fernandez, is thrilled about Fawcett's appointment, emphasizing his extensive technology and software experience. Fernandez is confident that Fawcett's experience will be instrumental for DXC's upcoming growth phase.
1
The company's significant liabilities and EBIT loss of US$790m over the last year raise concerns about its financial health. Without near-term improvements, the stock is considered risky.
Despite the CEO's modest remuneration, the company's ability to grow earnings going forward is questionable. The stock appears risky and requires thorough research before investing.
DXC Technology's low P/S ratio indicates poor revenue performance and future expectations. Without major changes, a significant stock price rise is unlikely. The weak revenue outlook pressures the stock.
Read more